期刊
JOURNAL OF NEUROSURGERY
卷 104, 期 2, 页码 272-277出版社
AMER ASSOC NEUROLOGICAL SURGEONS
DOI: 10.3171/jns.2006.104.2.272
关键词
traumatic brain injury; bone marrow stromal cell; growth factor; rat
Object. This study was designed to follow the effects of bone marrow stromal cell (BMSC) administration in rats after traumatic brain injury (TBI) for a 3-month period. Methods. Forty adult female Wistar rats were injured by a controlled cortical impact and, I week later, were injected intravenously with one of three different doses of BMSCs (2 X 10(6), 4 X 10(6), or 8 X 10(6) cells per animal) obtained in male rats. Control rats received phosphate-buffered saline (PBS). Neurological function in these rats was studied using a neurological severity scale (NSS). The rats were killed 3 months after injury, and immunohistochemical stains were applied to brain samples to study the distribution of the BMSCs. Additional brain samples were analyzed by quantitative enzyme-linked immunosorbent assays to measure the expression of the growth factors brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). Three months after injury, BMSCs were present in the injured brain and their number was significantly greater in animals that received 4 X 10(6) or 8 X 10(6) BMSCs than in animals that received 2 X 106 BMSCs, The cells were primarily distributed around the lesion boundary zone. Functional outcome was significantly better in rats that received 4 X 10(6) or 8 X 10(6) BMSCs, compared with control animals, although no improvement was seen in animals that received 2 X 10(6) BMSCs. All doses of BMSCs significantly increased the expression of BDNF but not that of NGF; however, this increase was significantly larger in animals that received 4 X 10(6) or 8 X 10(6) BMSCs than in controls or animals that received 2 X 10(6) BMSCs. Conclusions. In summary, when injected in rats after TBI, BMSCs are present in the brain 3 months later and significantly improve functional outcome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据